New iBox $USRM U.S. Department of Justice Files
Post# of 63700
U.S. Department of Justice Files Lawsuit
at Request of FDA to Stop U.S. Stem Cell Clinic
from Performing Autologous Stem Cell Procedure
USRM Will Vigorously Defend Medical Freedom of Americans
May 9, 2018 < >
Dr. Kristin Comella, USRM’s Chief Science Officer
$USRM on hold and weak $0.021
OTC
Website float 327M
hold x 60% sell
Filings and news
Developing the Future of Medicine.
We have treated over 4000 patients
We have trained over 600 practitioners
We have spent more than $125 million in research and development
We do not utilize harmful drugs to isolate cells from peripheral blood.
We have worked with several countries to help develop and write the regulations for stem cell therapy
Our protocols are being utilized in 6 continents
We are the inventors and developers of our own therapies
Treatment for Patients
Solutions for Veterinarians
Training for Physicians
Myocell
a muscle stem cell therapy
MyoCell SDF-1
Autologous cell therapy treatment for
severe chronic damage in the heart;
AdipoCell
The fat cells we use.
Clinical Trials and Recent Publications
US Stem Cell training courses